Evidence map›Paper›PMID 24403562›Full record

ArticleCirculation2014

Dantrolene: from better bacon to a treatment for ventricular fibrillation.

Dan M Roden, Björn C Knollmann

Abstract readEditorialComment
In one paragraph

Article in Circulation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Therapeutic Approaches of Ryanodine Receptor-Associated Heart Diseases.International journal of molecular sciences · 2022
    Review
  7. Emerging Antiarrhythmic Drugs for Atrial Fibrillation.International journal of molecular sciences · 2022
    Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Dan M RodenVanderbilt University School of Medicine, Nashville, TN.
Björn C Knollmann

Funding

MODULATION OF CARDIAC REPOLARIZATIONR01HL049989 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 1994 to 2015
$5.2M
Troponin T mutations and Sudden Cardiac DeathR01HL071670 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KNOLLMANN, BJORN C · 2003 to 2017
$4.5M
Calsequestrin in Ventricular Arrhythmia and Sudden DeathR01HL088635 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KNOLLMANN, BJORN C · 2007 to 2015
$3.2M
Flecainide for Catecholaminergic Polymorphic Ventricular TachycardiaR01HL108173 · NHLBI · VANDERBILT UNIVERSITY · PI KANNANKERIL, PRINCE JOSEPH, KNOLLMANN, BJORN C · 2011 to 2014
$2.2M
SCN5A mutations and dilated cardiomyopathyR01HL118952 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2014 to 2017
$1.6M
NHLBI NIH HHS R01 HL049989NHLBI NIH HHS R01 HL071670NHLBI NIH HHS R01 HL088635NHLBI NIH HHS R01 HL108173NHLBI NIH HHS R01 HL118952
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCalciumDantroleneMyocardial ContractionVentricular FibrillationCalciumDantrolenedantroleneEditorialsexcitation contraction couplingryanodine receptor calcium release channelventricular fibrillation

Identifiers

PMID24403562
PMCPMC3959791

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.